November 2, 2020
Study finds genetic predictors of cancer treatment side effects
Federico Innocenti, MD, PhD, and colleagues reported they have identified genetic predictors whether a person may be at risk of bevacizumab-induced hypertension.
November 2, 2020
Federico Innocenti, MD, PhD, and colleagues reported they have identified genetic predictors whether a person may be at risk of bevacizumab-induced hypertension.
October 30, 2020
Jenny Ting, PhD, and colleagues published a study showing bacteria mitigated radiation exposure and enhanced the recovery of blood cell production as well as repair of the gastrointestinal tract.
October 30, 2020
Surgical Oncologist Philip Spanheimer, MD, discusses and debunks four common misconceptions that breast cancer patients ask about care, treatment and diagnosis.
October 19, 2020
Angela Smith, MD, MS, FACS, is one of four recipients of the prize, which is awarded to faculty members who exemplify groundbreaking and innovative research.
October 19, 2020
Thomas Alexander, MD, MPH, and colleagues report on their work to help establish a pediatric hematology-oncology training curriculum in Ethiopia.
October 19, 2020
Early detection, caring doctors, family support and a community of survivors helped make a difference in Rachel Lezcano's battle with breast cancer.
October 19, 2020
Cancer Transitions is a free wellness workshop to help adult cancer survivors transition from active treatment. View upcoming workshop dates.
October 15, 2020
Lisa A. Carey, MD, FASCO, is the only breast cancer expert in N.C. and the Southeastern U.S. to earn the honor from Expertscape.
October 13, 2020
Adam Goldstein, MD, MPH, Trevor Jolly, MBBS, and Kimberly Shoenbill, MD, PhD, published an editorial in JAMA that states the case for more intensive smoking cessation programs for cancer patients.
October 12, 2020
Zongchao Han, MD, PhD, Barbara Savoldo, MD, PhD, and colleagues report in Nature Cancer they used a combination of CAR-Ts and interleukin (IL)-15 to treat retinoblastoma in a mouse model.